Take a look at these MSK-authored articles, recently published and having acquired over 100 Mendeley readers so far:

• Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018 Jan 5;359(6371):91-97. DOI: 10.1126/science.aan3706
• Senescence-associated reprogramming promotes cancer stemness. Nature. 2018 Jan 4;553(7686):96-100. DOI: 10.1038/nature25167
• Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018 Jan 11;378(2):158-168. DOI: 10.1056/NEJMra1703481

To see the demographic breakdown of readers, click on the Altmetric donut from the links above and click on “MENDELEY READERS.” See all MSK publications added to Synapse in February 2018.

Take a look at these MSK-authored articles, recently published and tweeted over 240 times thus far:

• Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017 Nov 23;551(7681):512-516. DOI: 10.1038/nature24462
• FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug. JAMA. 2017 Nov 21;318(19):1861-1862. DOI: 10.1001/jama.2017.15218
• Clinically meaningful benefit: Real world use compared against the American and European guidelines. Blood Cancer J. 2017 Dec 14;7(12):645. DOI: 10.1038/s41408-017-0009-8

To read the tweets, click on the Altmetric donut from the links above and go to “Twitter.” See all MSK publications added to Synapse in January 2018.